These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 30971924)

  • 1. Paradoxical Skin Reactions to Biologics in Patients With Rheumatologic Disorders.
    Garcovich S; De Simone C; Genovese G; Berti E; Cugno M; Marzano AV
    Front Pharmacol; 2019; 10():282. PubMed ID: 30971924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paradoxical Reactions: Anti-Tumor Necrosis Factor Alpha Agents, Ustekinumab, Secukinumab, Ixekizumab, and Others.
    Puig L
    Curr Probl Dermatol; 2018; 53():49-63. PubMed ID: 29131037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel and Off-Label Biologic Use in the Management of Hidradenitis Suppurativa, Pyoderma Gangrenosum, Lichen Planus, and Seborrheic Dermatitis: A Narrative Review.
    Mital R; Gray A; Minta A; Almhana F; Amin S; Hydol-Smith J; Mallela T; Kaffenberger BH
    Dermatol Ther (Heidelb); 2023 Jan; 13(1):77-94. PubMed ID: 36434425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Case of Paradoxical Reactions to Biologic Therapy for Psoriasis.
    Zhou Q; Zhou S; Xiong H; Yang J; Yang Z; Zhou N; Mao J; Li M
    Clin Cosmet Investig Dermatol; 2023; 16():1493-1497. PubMed ID: 37333515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current clinical issue of skin lesions in patients with inflammatory bowel disease.
    Iida T; Hida T; Matsuura M; Uhara H; Nakase H
    Clin J Gastroenterol; 2019 Dec; 12(6):501-510. PubMed ID: 30838512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous Manifestations of Reactions to Biologics.
    Otani IM; Levin AS; Banerji A
    Curr Allergy Asthma Rep; 2018 Feb; 18(2):12. PubMed ID: 29464437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin Manifestations of Inflammatory Bowel Disease.
    Greuter T; Navarini A; Vavricka SR
    Clin Rev Allergy Immunol; 2017 Dec; 53(3):413-427. PubMed ID: 28643285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory Joint Disorders and Neutrophilic Dermatoses: a Comprehensive Review.
    Cugno M; Gualtierotti R; Meroni PL; Marzano AV
    Clin Rev Allergy Immunol; 2018 Apr; 54(2):269-281. PubMed ID: 28735350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broad range of adverse cutaneous eruptions in patients on TNF-alpha antagonists.
    Hawryluk EB; Linskey KR; Duncan LM; Nazarian RM
    J Cutan Pathol; 2012 May; 39(5):481-92. PubMed ID: 22515220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical Reactions to Biologic Therapy in Psoriasis: A Review of the Literature.
    Munera-Campos M; Ballesca F; Carrascosa JM
    Actas Dermosifiliogr (Engl Ed); 2018 Nov; 109(9):791-800. PubMed ID: 29903464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of Paradoxical Reactions Associated with Targeted Biologic Agents for Inflammatory Skin Diseases.
    Miyagawa F
    Biomedicines; 2022 Jun; 10(7):. PubMed ID: 35884790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologics-Induced Immunophenotypic Cross-Switching in Patients with Psoriasis and Atopic Dermatitis.
    Li Y; Liu H; Zhang F
    Indian J Dermatol; 2023; 68(2):186-191. PubMed ID: 37275804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory Bowel Disease as a Paradoxical Reaction to Anti-TNF-α Treatment-A Review.
    Mihai IR; Burlui AM; Rezus II; Mihai C; Macovei LA; Cardoneanu A; Gavrilescu O; Dranga M; Rezus E
    Life (Basel); 2023 Aug; 13(8):. PubMed ID: 37629636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin Manifestations of Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, and Spondyloarthritides.
    Chua-Aguilera CJ; Möller B; Yawalkar N
    Clin Rev Allergy Immunol; 2017 Dec; 53(3):371-393. PubMed ID: 28752373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous manifestations in inflammatory bowel diseases: eight cases of psoriasis induced by anti-tumor-necrosis-factor antibody therapy.
    Passarini B; Infusino SD; Barbieri E; Varotti E; Gionchetti P; Rizzello F; Morselli C; Tambasco R; Campieri M
    Dermatology; 2007; 215(4):295-300. PubMed ID: 17911986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous Manifestations in Biological-Treated Inflammatory Bowel Disease Patients: A Narrative Review.
    Lambert JLW; De Schepper S; Speeckaert R
    J Clin Med; 2021 Mar; 10(5):. PubMed ID: 33802483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ustekinumab treatment of TNF antagonist-induced paradoxical psoriasis flare in a patient with psoriatic arthritis: case report and review.
    Puig L; Morales-Múnera CE; López-Ferrer A; Geli C
    Dermatology; 2012; 225(1):14-7. PubMed ID: 22890275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous manifestations in patients with inflammatory bowel diseases: pathophysiology, clinical features, and therapy.
    Marzano AV; Borghi A; Stadnicki A; Crosti C; Cugno M
    Inflamm Bowel Dis; 2014 Jan; 20(1):213-27. PubMed ID: 24105394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of abatacept associated neutrophilic dermatosis and a review of the literature.
    Tiwari SM; Wood BA; Skender-Kalnenas T; Cook N
    Australas J Dermatol; 2014 Aug; 55(3):214-7. PubMed ID: 25117161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.